December 21, 2018 C-Path Board Member Paula Olsiewski Honored as AAAS 2018 Elected Fellow Paula Olsiewski, Ph.D., program director at the Alfred P. Sloan Foundation and Critical Path Institute board member, was named a 2
December 19, 2018 In Recognition of 10th Anniversary, Raymond Woosley and Janet Woodcock Address CPAD Consortium’s 2018 Annual Meeting and Regulatory Science Workshop At its 10th Annual Meeting and Regulatory Science Workshop, November 13, 2018, in Bethesda, MD, C-Path’s Critical Path for Alzhe
December 18, 2018 Critical Path Institute Encouraged by FDA to Move Forward on Type 1 Diabetes Biomarker Initiative Biomarker potentially could identify individuals at risk of developing T1D TUCSON, Ariz., December 18, 2018 — Critical Path Inst
December 17, 2018 CPTR Newsletter – December 2018 CPTR Newsletter – December 2018 In this issue: In the Spotlight: TB-ReFLECT Manuscript Published Updates to the TB
December 12, 2018 U.S. Food and Drug Administration Awards Contract to Critical Path Institute for Kidney Transplant Database Patient-level data will inform the creation of drug development tools and speed development of new immunosuppressive treatments TU
December 1, 2018 Brief Overview: Assessment of Compound-induced Acute Kidney Injury Using Animal Models, Biomarkers, and In Vitro Platforms
November 28, 2018 Sharing Data to Accelerate Medicines Development and Improve Neonatal Care: Data Standards and Harmonized Definitions
November 8, 2018 Profiles in Business with Tucson Metro Chamber C-Path President and CEO Martha Brumfield, Ph.D., talks about today’s drug discovery process, C-Path’s global impact a
November 5, 2018 Critical Path Institute Rebrands One of Its First Consortia to Highlight Focus on Alzheimer’s Disease Critical Path for Alzheimer’s Disease (CPAD) consortium’s refined, refocused mission centers on accelerating therapy developme
November 3, 2018 D-RSC and PSTC presented “Biomarkers for Muscle Diseases” poster at the 2018 MDA Clinical Conference
